Publications
Bloom AI, Gordon RL, Ahl KH, Kerlan RK, LaBerge JM, Wilson MW, Venook AP, Warren R. Transcatheter embolization for the treatment of misperfusion after hepatic artery chemoinfusion pump implantation. Annals of surgical oncology. 1999. PMID: 10379855
Fornier M, Munster P, Seidman AD. Update on the management of advanced breast cancer. Oncology (Williston Park, N.Y.). 1999. PMID: 10356685
Small EJ. Advances in prostate cancer. Current opinion in oncology. 1999. PMID: 10328599
Reese DM, Small EJ. Secondary hormonal manipulations in hormone refractory prostate cancer. The Urologic clinics of North America. 1999. PMID: 10361554
Bok RA, Small EJ. The treatment of advanced prostate cancer with ketoconazole: safety issues. Drug safety. 1999. PMID: 10348095
Scanlan MJ, Williamson B, Jungbluth A, Stockert E, Arden KC, Viars CS, Gure AO, Gordan JD, Chen YT, Old LJ. Isoforms of the human PDZ-73 protein exhibit differential tissue expression. Biochimica et biophysica acta. 1999. PMID: 10209257
Coakley FV, Hricak H, Presti JC, Small EJ. Diffuse retroperitoneal amyloidosis due to renal cell carcinoma. The British journal of radiology. 1999. PMID: 10474508
Talley EM, Cribbs LL, Lee JH, Daud A, Perez-Reyes E, Bayliss DA. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. The Journal of neuroscience : the official journal of the Society for Neuroscience. 1999. PMID: 10066243
Vescio R, Schiller G, Stewart AK, Ballester O, Noga S, Rugo H, Freytes C, Stadtmauer E, Tarantolo S, Sahebi F, Stiff P, Meharchard J, Schlossman R, Brown R, Tully H, Benyunes M, Jacobs C, Berenson R, DiPersio J, Anderson K, Berenson J. Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood. 1999. PMID: 10068658
Melnyk O, Zimmerman M, Kim KJ, Shuman M. Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model. The Journal of urology. 1999. PMID: 10022734
Rubin J, Ajani J, Schirmer W, Venook AP, Bukowski R, Pommier R, Saltz L, Dandona P, Anthony L. Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999. PMID: 10080605
Venook AP. Embolization and chemoembolization therapy for neuroendocrine tumors. Current opinion in oncology. 1999. PMID: 9914876
Chang JC, Lu R, Lin C, Xu SM, Kan YW, Porcu S, Carlson E, Kitamura M, Yang S, Flebbe-Rehwaldt L, Gaensler KM. Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia. Proceedings of the National Academy of Sciences of the United States of America. 1998. PMID: 9843985
Dellovade T, Schwanzel-Fukuda M, Gordan J, Pfaff D. Aspects of GnRH neurobiology conserved across vertebrate forms. General and comparative endocrinology. 1998. PMID: 9843633
Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report. Bone marrow transplantation. 1998. PMID: 9827814
Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report. Bone marrow transplantation. 1998. PMID: 9827814
Martin TG, Shuman MA. Interferon-induced thrombocytopenia: is it time for thrombopoietin. Hepatology (Baltimore, Md.). 1998. PMID: 9794932
Martin TG, Shuman MA. Interferon-induced thrombocytopenia: is it time for thrombopoietin. Hepatology (Baltimore, Md.). 1998. PMID: 9794932
Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report. Bone marrow transplantation. 1998. PMID: 9827814
Huang SS, Huang FW, Xu J, Chen S, Hsu CY, Huang JS. Amyloid beta-peptide possesses a transforming growth factor-beta activity. The Journal of biological chemistry. 1998. PMID: 9765299